Long-Term Response to PD-1 and CTLA-4 Blockade in an SCLC Patient with Negative PD-L1 Expression on Biopsy: A Case Report by Marco Cefalì, Francesco Martucci, Patrizia Frösch

Get full text

Precision Oncology in Gastro-Esophageal Adenocarcinoma by Marco Cefalì, Celeste Palmarocchi, Sara De Dosso

Get full text

The Evolving Systemic Treatment for Advanced Hepatocellular Carcinoma by Sara De Dosso, Marco Cefali, Maria Celeste Palmarocchi

Get full text

Multidisciplinary Approach to a Patient with Acinar Cell Carcinoma, a Rare Pancreatic Malignancy by Maria Celeste Palmarocchi, Elisabetta Merlo, Marco Cefali, Sara De Dosso

Get full text

Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis by Caroline-Claudia Erhart, Marco Cefalì, Dylan Mangan, Benjamin Kasenda, Luicano Wannesson

Get full text

Benefits and Complications Following First-Line Treatment with Atezolizumab plus Bevacizumab in a Patient with HCC: a Case Report by Maria Celeste Palmarocchi, Marco Cefali, Antonio Galante, Stefania Rizzo, Sara De Dosso

Get full text

Benefits and Complications Following First-Line Treatment with Atezolizumab plus Bevacizumab in a Patient with HCC: a Case Report by Maria Celeste Palmarocchi, Marco Cefali, Antonio Galante, Stefania Rizzo, Sara De Dosso

Get full text

Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review by Stefania Rizzo, Stefania Rizzo, Isabel Scala, Angela Rodriguez Robayo, Marco Cefalì, Sara De Dosso, Sara De Dosso, Stefano Cappio, Genti Xhepa, Filippo Del Grande, Filippo Del Grande

Get full text